Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Eden Research ( (GB:EDEN) ) has issued an announcement.
Eden Research plc announced that its CEO and CFO will present the company’s Full Year Results on May 14, 2025, via a live presentation open to existing and potential shareholders. This event provides an opportunity for stakeholders to engage with the company’s leadership and gain insights into its financial performance and strategic direction. The announcement underscores Eden’s commitment to transparency and stakeholder engagement, potentially strengthening its position in the sustainable agriculture sector.
More about Eden Research
Eden Research plc is a UK-listed company specializing in sustainable biopesticide and biocontrol technology. It develops and supplies innovative biopesticide products and natural microencapsulation technologies for the global crop protection, animal health, and consumer products industries. The company’s products, which include Mevalone, Novellus, Cedroz, and Ecovelex, are based on plant-derived active ingredients and are designed to improve crop yields and marketability while addressing environmental concerns. Eden Research is recognized for its contribution to the global green economy, deriving 100% of its revenue from sustainable products and services.
Average Trading Volume: 467,204
Technical Sentiment Signal: Sell
Current Market Cap: £14.67M
Find detailed analytics on EDEN stock on TipRanks’ Stock Analysis page.